Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Francisco Alexandrino-Junior"'
Autor:
Carla Soares de Souza, Victor Ropke da Cruz Lopes, Gabriel Barcellos, Francisco Alexandrino-Junior, Patrícia Cristina da Costa Neves, Beatriz Ferreira de Carvalho Patricio, Helvécio Vinícius Antunes Rocha, Ana Paula Dinis Ano Bom, Alexandre Bezerra Conde Figueiredo
Publikováno v:
Journal of Fungi, Vol 10, Iss 5, p 344 (2024)
Fungal infections cause 1.7 million deaths annually, which can be attributed not only to fungus-specific factors, such as antifungal resistance and biofilm formation, but also to drug-related challenges. In this study, the potential of Amphotericin (
Externí odkaz:
https://doaj.org/article/353d664351fa4006ad263968fef3affc
Autor:
Francisco Alexandrino-Junior, Kattya Gyselle de Holanda e Silva, Marjorie Caroline Liberato Cavalcanti Freire, Viviane de Oliveira Freitas Lione, Elisama Azevedo Cardoso, Henrique Rodrigues Marcelino, Julieta Genre, Anselmo Gomes de Oliveira, Eryvaldo Sócrates Tabosa do Egito
Publikováno v:
Pharmaceutics, Vol 11, Iss 5, p 200 (2019)
Cutaneous leishmaniasis (CL) is a parasitic disease characterized by progressive skin sores. Currently, treatments for CL are limited to parenteral administration of the drug, which presents severe adverse effects and low cure rates. Therefore, this
Externí odkaz:
https://doaj.org/article/8cdff90da6ed4817a67c1f22b00bf6cf
Autor:
Kattya Gyselle de Holanda e Silva, Henrique Rodrigues Marcelino, Anselmo Gomes de Oliveira, Viviane de Oliveira Freitas Lione, Marjorie Caroline Liberato Cavalcanti Freire, Elisama Azevedo Cardoso, Francisco Alexandrino-Junior, Julieta Genre, Eryvaldo Sócrates Tabosa do Egito
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Pharmaceutics
Volume 11
Issue 5
Pharmaceutics, Vol 11, Iss 5, p 200 (2019)
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
Pharmaceutics
Volume 11
Issue 5
Pharmaceutics, Vol 11, Iss 5, p 200 (2019)
Cutaneous leishmaniasis (CL) is a parasitic disease characterized by progressive skin sores. Currently, treatments for CL are limited to parenteral administration of the drug, which presents severe adverse effects and low cure rates. Therefore, this